- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02877030
Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus
June 4, 2019 updated by: Érika Pedreira, Pedreira, Érika, M.D.
Sensorimotor Exercises in Virtual Reality Platform and Balance in Individuals With Human T-lymphotropic Virus
Testing the effectiveness of an exercise protocol engines sensory performed through a virtual reality platform in individuals infected with HTLV-1
Study Overview
Detailed Description
Crossover randomized clinical trial to be conducted with people having a previous diagnosis of HTLV-1, they can remain in standing position without assistance.
They will be excluded from those presenting amputation of the lower limbs, pregnancy, psychiatric disorders, rheumatic or orthopedic diseases, other neurological disorders associated and those that are experiencing difficulty in understanding the assessment tools used.
They will also be recruited to a comparative group, healthy individuals, matched for sex, age and education level.
It will be performed three assessments, before randomization, after 10 weeks and after 20 weeks, which will be evaluated in balance, functional mobility, gait and posture.
The participants infected with HTLV-1, will be divided into two groups by random distribution, a group will begin the treatment protocol with video game immediately after the first evaluation and the other after ten weeks, with the crossing of the groups .
Concealment of allocation will be guaranteed to the examiners who will have no contact with the physiotherapist who will apply the exercise protocol and the team member responsible for drawing.
Patients will also be instructed to maintain confidentiality of the entry in the exercise program to other patients and examiners.
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bahia
-
Salvador, Bahia, Brazil, 40000-00
- Universidade Católica do Salvador
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- people having a previous diagnosis of HTLV-1, which can remain in standing position without assistance.
Exclusion Criteria:
- amputation of the lower limbs, pregnancy, psychiatric disorders, rheumatic or orthopedic diseases, other neurological disorders associated and those that are experiencing difficulty in understanding the assessment tools used.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Test control group
Start the sensorimotor exercises protocol with video game immediately after the first evaluation
|
The protocol sensorimotor exercises consist of a virtual game that attaches to the Nintendo Wii and using arrows that are thrown from above, players must perform weight-shifting movements in the Nintendo platform to the target be directed to the trajectory the arrows.
The goal is to catch as many arrows.
|
|
ACTIVE_COMPARATOR: Control test group
Start of sensorimotor exercises with video game protocol after ten weeks
|
The protocol sensorimotor exercises consist of a virtual game that attaches to the Nintendo Wii and using arrows that are thrown from above, players must perform weight-shifting movements in the Nintendo platform to the target be directed to the trajectory the arrows.
The goal is to catch as many arrows.
|
|
NO_INTERVENTION: comparison group
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed up and Go
Time Frame: average 8 weeks
|
Functional mobility in patients with HTLV-1 undergoing rehabilitation with video game
|
average 8 weeks
|
|
Gait performance at CvMob (Software for movement analysis)
Time Frame: an average 8 weeks
|
Gait performance in patients with HTLV-1 undergoing rehabilitation with video game
|
an average 8 weeks
|
|
Posture analysis at CvMob (Software for movement analysis)
Time Frame: average 8 weeks
|
Posture analysis in patients with HTLV-1 undergoing rehabilitation with video game
|
average 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Pain Inventory (BPI)
Time Frame: average 8 weeks
|
Pain in patients with HTLV-1 undergoing rehabilitation with video game
|
average 8 weeks
|
|
WHOQOL BRIEF
Time Frame: average 8 weeks
|
Quality of life in patients with HTLV-1 undergoing rehabilitation with video game
|
average 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erika Fonseca, M.D., Pedreira, Érika, M.D.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 2, 2017
Primary Completion (ACTUAL)
December 20, 2017
Study Completion (ACTUAL)
May 5, 2018
Study Registration Dates
First Submitted
August 11, 2016
First Submitted That Met QC Criteria
August 18, 2016
First Posted (ESTIMATE)
August 24, 2016
Study Record Updates
Last Update Posted (ACTUAL)
June 6, 2019
Last Update Submitted That Met QC Criteria
June 4, 2019
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- PedreiraE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HTLV-1
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinActive, not recruitingHTLV-1 Infection | Lymphoproliferation Induced by HTLV-1 | HTLV-1 Adult T-cell Lymphoma / LeukemiaFrance
-
First Affiliated Hospital of Fujian Medical UniversityRecruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedHTLV-1-Associated Myelopathy (HAM)Japan
-
Kyowa Kirin Co., Ltd.TerminatedHTLV-1 Associated MyelopathyJapan
-
MP Biomedicals, LLCMP Biomedicals Asia Pacific Pte. Ltd.CompletedHTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated MyelopathiesUnited States
-
MP Biomedicals, LLCVital Systems Inc.UnknownHTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated MyelopathiesUnited States
-
MP Biomedicals, LLCMP Biomedicals Asia Pacific Pte. Ltd.CompletedHTLV-I Infections | HTLV-II Infections | Human T-lymphotropic Virus 1 | Human T-lymphotropic Virus 2 | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated MyelopathiesUnited States
-
Carlos BritesRecruitingNeuritis | HTLV-1 Infection | HTLV I Associated T Cell Leukemia Lymphoma | HTLV I Associated MyelopathiesBrazil
-
National Institute of Neurological Disorders and...CompletedTropical Spastic Paraparesis | Spinal Cord Disease | HTLV-I InfectionUnited States
-
St. Marianna University School of MedicineUnknownHTLV-I-Associated MyelopathyJapan
Clinical Trials on Video game
-
University of Wisconsin, MadisonBrain & Behavior Research FoundationCompleted
-
Brigham Young UniversityCompleted
-
San Francisco Veterans Affairs Medical CenterVA Office of Research and DevelopmentCompletedTBI (Traumatic Brain Injury)United States
-
Yale UniversityCompleted
-
Anne KloosCompletedHuntington's DiseaseUnited States
-
Université Blaise Pascal, Clermont-FerrandWithdrawnPassive Video Games (PVG) | Active Video Games (AVG) | Exercise (EX)France
-
Massachusetts Eye and Ear InfirmaryWithdrawnHigh-Frequency Hearing Loss
-
Federal University of ParaíbaCompleted
-
Boston University Charles River CampusCarnegie Mellon UniversityWithdrawnAutism Spectrum Disorder | AutismUnited States